Авторы

  • Tursunov D.H., Omonov A.A., Inoyatova F.H., Rakhmanov A.H., Khayitov M.S.

Ключевые слова:

alloxan diabetes, lipid peroxidation, pulmonary fibrosis, oxidative stress, elastin, pulmonology, chronic inflammatory

Библиографические ссылки

Abusueva A. S. i dr. Perekisnoe okislenie lipidov u bolnix razlichnimi formami brutselleza //Ekologicheskaya meditsina. – 2018. – T. 1. – №. 1. – S. 50-53.

Andreeva L.I., Kojemyakin L.A., Kishkun A.A. Modifikatsiya metoda opredeleniya perekisey lipidov v teste s tiobarbiturovoy kislotoy // Labotornoe delo.-1988.-№11.-S.41-43.

Blackwell T.S., Tager A.M., Borok Z. et al. Future directions in idiopathic pulmonary fibrosis research. // Am J Respir Crit Care Med. – 2014; 189(2): 214–222.

Good laboratory practice, GLP [GOST O´zDSt 2762:2018 «Nadlejashaya laboratornaya praktika», Tashkent 2018.ttps://uzpharm-gxp.uz.

Kayumova Yu.D., Tadjixodjaeva Yu.X. Eksperimentalnaya model xronicheskoy obstruktivnoy bolezni lyogkix s tabakokureniem v izuchenii membranodestruktivnix protsessov // Vestnik assotsiatsii pulmonologov tsentralnoy azii.- 2020; vipusk 18 (№1-4), S.22-26.

Koralyuk M.I. i dr. Metod opredeleniya aktivnosti katalazi // Laboratornoe delo.- 1988.- №1.- S.16–19.

Leonova Ye.I., Shmelev Ye.I., Shergina N. Izmeneniya sosudistoy jyostkosti pri idiopaticheskom fibroze lyogkix. – 2019.

Maher T.M. Idiopathic pulmonary fibrosis: pathobiology and novel approaches to treatment. // Clin Chest Med. – 2012; 33(1): 69–83.

Toussaint O., Houbion A., Remacle J. Relationship between the critical level of oxidative stresses and the glutathione peroxidase activity //Toxicology. – 1993. – Т. 81. – №. 2. – С. 89-101.

Mxitaryan V.G., Badalyan G.Ye. Vliyanie peroksidirovannыx i neperoksidirovannыx nenasishennix jirnix kislot na aktivnost superoksiddismutazi. //Jurnal eksperimentalnoy i klinicheskoy meditsini –1978. -№6. –S.7-11.

Peljto A.L., Zhang Y., Fingerlin T.E. et al. The MUC5B promoter polymorphism is associated with pulmonary fibrosis. // N Engl J Med. – 2013; 368(3): 219–228.

Petrova S. A. Oksidativniy stress i antioksidantnaya sistema pri jirovom gepatoze // Bioximicheskiy jurnal. -2024. –V. 29(4). –P. 567-578.

Serviddio G, Bellanti F, Vendemiale G. Free radical biology for medicine: learning from nonalcoholic fatty liver disease // Free Radic Biol Med. -2013. –V. 65. –P. 952-968.

Spravochnik Vidal «Lekarstvennie preparati v Rossii», https://www.vidal.ru/drugs/ecdisten__33965.

Stefanov A.V. Doklinicheskie issledovaniya lekarstvennix sredstv., Kiev 2002. – s. 91.

Stupnitskaya A.Ya. Xronicheskoe sistemnoe vospalenie pri XOBL i metabolicheskom sindrome. – 2014.

Wang Y., Kuan P.J., Xing C. et al. Genetic studies in familial pulmonary fibrosis. // Am J Respir Crit Care Med. – 2009; 179(5): 367–373.

Xia H., Bodempudi V., Benyumov A. et al. Fibroblast recruitment and proliferation in pulmonary fibrosis. // J Biol Chem. – 2014; 289(7): 4790–4802.